Immunoassays bearing the CE designation are developed in various technologies in accordance with customer requirements in the Department of Development. The focus is on the realization of completely automatic trace-technology testing procedures for KRYPTOR. Additionally, manual testing systems are being developed, primarily as luminescence assays.

Increasingly, we will also be offering rapid-result testing in point-of-care technology.

For further scientific information, please see our publication list. We are also available to you personally.